湖南方盛制药股份有限公司2025年特别分红权益分派实施公告

Core Viewpoint - Hunan Fangsheng Pharmaceutical Co., Ltd. announced a special cash dividend of 0.15 RMB per share for the fiscal year 2025, totaling approximately 65.86 million RMB, following the approval from the shareholders' meeting and the board of directors [1][3]. Dividend Distribution Plan - The special dividend is based on a total share capital of 439,081,360 shares, with a cash distribution of 0.15 RMB per share, amounting to a total cash dividend of 65,862,204 RMB [3]. - The dividend will be distributed to all shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [2]. Implementation Details - The cash dividends will be distributed through the clearing system of China Securities Depository and Clearing Corporation Limited, with shareholders who have completed designated transactions able to receive their dividends on the payment date [4]. - For shareholders who have not completed designated transactions, the dividends will be held by China Securities Depository and Clearing Corporation Limited until the transactions are completed [4]. Taxation Information - For individual shareholders holding unrestricted A-shares, the tax treatment varies based on the holding period: - Holding period within 1 month: 20% tax on dividends - Holding period between 1 month and 1 year: 10% effective tax rate - Holding period over 1 year: exempt from personal income tax [6][7]. - For qualified foreign institutional investors (QFII), a 10% corporate income tax will be withheld, resulting in a net dividend of 0.135 RMB per share [8]. Compliance and Inspection - The company received a non-compliance notice from the Hunan Provincial Drug Administration regarding the production of the raw material indobufen, due to outdated standards during the production process [10]. - The company is currently in the preparation stage for the market launch of indobufen and has initiated corrective actions to address the issues identified during the inspection [11].